+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nicotine Gum Market - Growth, Trends and Forecast (2020 - 2025)

  • ID: 4987113
  • Report
  • February 2020
  • Region: Global
  • 104 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • British American Tobacco
  • Cipla Health Limited
  • GlaxoSmithKline plc
  • ITC Limited
  • Johnson & Johnson
  • Novartis AG
  • MORE
The Global Nicotine Gum Market is projected to register a CAGR of ~5.1% during the study period (2020-2025).
  • The growing awareness regarding health hazards associated with smoking, which has resulted in a rise in the number of people trying to quit smoking is the major factor driving market growth. Moreover, the market has witnessed a significant increase in demand from medical institutions and rehab clinics for the purpose of nicotine cessation, in both the developed and developing countries across the globe.
  • Furthermore, an increase in government initiatives across various countries to control tobacco consumption is also a prime factor rising the sales of nicotine gum, globally.
Key Market Trends

Rising Awareness Regarding Health Hazards Associated with Smoking

Globally, there has been a significant rise in government focus to reduce smoking rates, Governments across the regions are adopting comprehensive approaches to control tobacco consumption. This include a range of measures such as ban on tobacco advertising and promotion; restrictions on smoking in public places and in the workplace; sustained increases in tobacco taxation combined with measures to curb smuggling; large, bold health warnings on tobacco products; smoking cessation and health education campaigns; and the regulation of tobacco to standards and many others. Such measures have increased the consumers to look for alternatives to reduce tobacco consumption driving demand for the nicotine gum market.

North America Holds Significant Share in the Market

North America has experienced an increase in the percentage of health consciousness consumers supported by government initiatives and campaigns driving the growth of the market in the region. Moreover, the region has the presence of major brands focusing on product innovations to capture the growing demand and achieve a competitive advantage in the market. For instance, Nicorette has launched a new nicotine gum product coated ice mint lozenge with a smoother texture. Such factors are anticipated to drive the market growth during the study period. The United States holds the major share in the North America nicotine gum market.

Competitive Landscape

The global nicotine gum market is a fragmented market with the presence of various regional and global players. Moreover, the market has the presence of many private label nicotine gum brands owing to growing demand. Companies make themselves competitive by expanding product offerings, improving taste, flavors, functionality, and marketing activities. Key players in the market include British American Tobacco, GlaxoSmithKline plc, ITC Limited, Johnson & Johnson, Novartis AG, among others.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • British American Tobacco
  • Cipla Health Limited
  • GlaxoSmithKline plc
  • ITC Limited
  • Johnson & Johnson
  • Novartis AG
  • MORE
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

3.1 Market Overview

4 MARKET DYNAMICS

4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type
5.1.1 2 mg Nicotine Gum
5.1.2 4 mg Nicotine Gum
5.2 By Distribution Channels
5.2.1 Supermarkets/Hypermarkets
5.2.2 Convenience Stores/Tobacco Stores
5.2.3 Online Retail Stores
5.2.4 Other Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Spain
5.3.2.2 United Kingdom
5.3.2.3 Germany
5.3.2.4 France
5.3.2.5 Italy
5.3.2.6 Russia
5.3.2.7 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East and Africa
5.3.5.1 South Africa
5.3.5.2 United Arab Emirates
5.3.5.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 British American Tobacco
6.3.2 GlaxoSmithKline plc
6.3.3 ITC Limited
6.3.4 Johnson & Johnson
6.3.5 Novartis AG
6.3.6 Perrigo Company plc
6.3.7 Takeda Consumer Healthcare Company Limited
6.3.8 Cipla Health Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • British American Tobacco
  • GlaxoSmithKline plc
  • ITC Limited
  • Johnson & Johnson
  • Novartis AG
  • Perrigo Company plc
  • Takeda Consumer Healthcare Company Limited
  • Cipla Health Limited
Note: Product cover images may vary from those shown
Adroll
adroll